112 related articles for article (PubMed ID: 10083042)
1. In vivo differentiation of alloreactive CD8+ T cells after murine cardiac allograft transplantation.
Gilot BJ; Hara M; Jones ND; van Maurik A; Hadjianastassiou V; Morris PJ; Wood KJ
Transplant Proc; 1999; 31(1-2):130. PubMed ID: 10083042
[No Abstract] [Full Text] [Related]
2. Indirect allorecognition is involved in both acute and chronic allograft rejection.
Fluck N; Witzke O; Morris PJ; Wood KJ
Transplant Proc; 1999; 31(1-2):842-3. PubMed ID: 10083366
[No Abstract] [Full Text] [Related]
3. Activation of alloreactive CD8+ T cells operates via CD4-dependent and CD4-independent mechanisms and is CD154 blockade sensitive.
Zhai Y; Meng L; Busuttil RW; Sayegh MH; Kupiec-Weglinski JW
J Immunol; 2003 Mar; 170(6):3024-8. PubMed ID: 12626556
[TBL] [Abstract][Full Text] [Related]
4. Visualization of the in vivo generation of donor antigen-specific effector CD8+ T cells during mouse cardiac allograft rejection: in vivo effector CD8+ T cell generation during allograft rejection.
Gilot BJ; Hara M; Jones ND; van Maurik A; Niimi M; Hadjianastassiou V; Morris PJ; Wood KJ
Transplantation; 2000 Feb; 69(4):639-48. PubMed ID: 10708123
[TBL] [Abstract][Full Text] [Related]
5. Treatment of allograft recipients with donor-specific transfusion and anti-CD154 antibody leads to deletion of alloreactive CD8+ T cells and prolonged graft survival in a CTLA4-dependent manner.
Iwakoshi NN; Mordes JP; Markees TG; Phillips NE; Rossini AA; Greiner DL
J Immunol; 2000 Jan; 164(1):512-21. PubMed ID: 10605049
[TBL] [Abstract][Full Text] [Related]
6. Increased expression of the lymphocyte early activation marker CD69 in peripheral blood correlates with histologic evidence of cardiac allograft rejection.
Schowengerdt KO; Fricker FJ; Bahjat KS; Kuntz ST
Transplantation; 2000 May; 69(10):2102-7. PubMed ID: 10852605
[TBL] [Abstract][Full Text] [Related]
7. Non-hematopoietic allograft cells directly activate CD8+ T cells and trigger acute rejection: an alternative mechanism of allorecognition.
Kreisel D; Krupnick AS; Gelman AE; Engels FH; Popma SH; Krasinskas AM; Balsara KR; Szeto WY; Turka LA; Rosengard BR
Nat Med; 2002 Mar; 8(3):233-9. PubMed ID: 11875493
[TBL] [Abstract][Full Text] [Related]
8. Commentary: Priming of alloreactive T cells--where does it happen?
Golshayan D; Lechler R
Eur J Immunol; 2004 Dec; 34(12):3301-4. PubMed ID: 15484195
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of peripheral blood CD4 and CD8 lymphocyte subsets, CD69 expression and histologic rejection grade as diagnostic markers for the presence of cardiac allograft rejection.
Creemers P; Brink J; Wainwright H; Moore K; Shephard E; Kahn D
Transpl Immunol; 2002 Nov; 10(4):285-92. PubMed ID: 12507400
[TBL] [Abstract][Full Text] [Related]
10. Impaired signaling in alloantigen-specific CD8+ T cells tolerized in vivo: employing a model of Ld-specific TCR transgenic mice transplanted with allogenic hearts under the cover of a short-term rapamycin treatment.
Chen H; Luo H; Xu D; Loh DY; Daloze PM; Veillette A; Qi S; Wu J
J Immunol; 1996 Nov; 157(10):4297-308. PubMed ID: 8906803
[TBL] [Abstract][Full Text] [Related]
11. CD40-CD40 ligand-independent activation of CD8+ T cells can trigger allograft rejection.
Jones ND; Van Maurik A; Hara M; Spriewald BM; Witzke O; Morris PJ; Wood KJ
J Immunol; 2000 Jul; 165(2):1111-8. PubMed ID: 10878390
[TBL] [Abstract][Full Text] [Related]
12. Intrathymic alloantigen-mediated, tolerant, completely major histocompatibility complex-mismatched mouse hearts are specifically rejected by adoptively transferred anti-class I L(d+)-specific 2C cells.
Otomo N; Motoyama K; Yu S; Shimizu Y; Margenthaler J; Tu F; Flye MW
Surgery; 2000 Aug; 128(2):206-12. PubMed ID: 10922993
[TBL] [Abstract][Full Text] [Related]
13. CD8 T cells are sufficient to mediate allorecognition and allograft rejection.
Halamay KE; Kirkman RL; Sun L; Yamada A; Fragoso RC; Shimizu K; Mitchell RN; McKay DB
Cell Immunol; 2002; 216(1-2):6-14. PubMed ID: 12381345
[TBL] [Abstract][Full Text] [Related]
14. Allograft rejection by primed/memory CD8+ T cells is CD154 blockade resistant: therapeutic implications for sensitized transplant recipients.
Zhai Y; Meng L; Gao F; Busuttil RW; Kupiec-Weglinski JW
J Immunol; 2002 Oct; 169(8):4667-73. PubMed ID: 12370407
[TBL] [Abstract][Full Text] [Related]
15. Analysis of the role of negative T cell costimulatory pathways in CD4 and CD8 T cell-mediated alloimmune responses in vivo.
Ito T; Ueno T; Clarkson MR; Yuan X; Jurewicz MM; Yagita H; Azuma M; Sharpe AH; Auchincloss H; Sayegh MH; Najafian N
J Immunol; 2005 Jun; 174(11):6648-56. PubMed ID: 15905503
[TBL] [Abstract][Full Text] [Related]
16. CCR4-deficient mice show prolonged graft survival in a chronic cardiac transplant rejection model.
Hüser N; Tertilt C; Gerauer K; Maier S; Traeger T; Assfalg V; Reiter R; Heidecke CD; Pfeffer K
Eur J Immunol; 2005 Jan; 35(1):128-38. PubMed ID: 15593118
[TBL] [Abstract][Full Text] [Related]
17. CD70 signaling is critical for CD28-independent CD8+ T cell-mediated alloimmune responses in vivo.
Yamada A; Salama AD; Sho M; Najafian N; Ito T; Forman JP; Kewalramani R; Sandner S; Harada H; Clarkson MR; Mandelbrot DA; Sharpe AH; Oshima H; Yagita H; Chalasani G; Lakkis FG; Auchincloss H; Sayegh MH
J Immunol; 2005 Feb; 174(3):1357-64. PubMed ID: 15661893
[TBL] [Abstract][Full Text] [Related]
18. CD4-positive helper T lymphocytes mediate mouse cardiac allograft rejection independent of donor alloantigen specific cytotoxic T lymphocytes.
Bishop DK; Chan S; Li W; Ensley RD; Xu S; Eichwald EJ
Transplantation; 1993 Oct; 56(4):892-7. PubMed ID: 8212213
[TBL] [Abstract][Full Text] [Related]
19. The replacement of graft endothelium by recipient-type cells conditions allograft rejection mediated by indirect pathway CD4+ T cells.
Kapessidou Y; Habran C; Buonocore S; Flamand V; Barvais L; Goldman M; Braun MY
Transplantation; 2006 Aug; 82(4):582-91. PubMed ID: 16958183
[TBL] [Abstract][Full Text] [Related]
20. Type 2 immune deviation has differential effects on alloreactive CD4+ and CD8+ T cells.
Matesic D; Valujskikh A; Pearlman E; Higgins AW; Gilliam AC; Heeger PS
J Immunol; 1998 Nov; 161(10):5236-44. PubMed ID: 9820495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
